ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,585
-0,36%
Bitcoin
60 009,91
-0,97%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. OpGen Inc (OPGN)

  7. OpGen Inc (OPGN) Actualités

OPGN OpGen Inc

0,449
-0,086 (-16,07%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
OpGen Inc OPGN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,086 -16,07% 0,449 01:44:30
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,50 0,4026 0,50 0,403 0,535
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202422:05GLOBEOpGen Provides Update on Business Operations and Strategic..
23/4/202422:15GLOBEOpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
26/3/202421:20APSShares Rip In Reaction To Activist Investor Becoming CEO
25/3/202421:05GLOBEOpGen Announces Acquisition of Preferred Stock by David..
13/2/202422:30EDGAR2Form 8-K - Current report
08/2/202413:30EDGAR2Form 8-K - Current report
09/1/202422:30EDGAR2Form 8-K - Current report
12/12/202322:58EDGAR2Form 8-K - Current report
05/12/202322:37EDGAR2Form 8-K - Current report
24/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202322:30GLOBEOpGen Reports Third Quarter 2023 Financial Results and..
13/11/202322:59EDGAR2Form S-3 - Registration statement under Securities Act of..
07/11/202322:30EDGAR2Form 8-K - Current report
26/10/202322:30EDGAR2Form 8-K - Current report
16/10/202322:30EDGAR2Form 8-K - Current report
13/10/202323:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/10/202323:17EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/10/202323:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/10/202323:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/10/202323:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/10/202318:32GLOBEOpGen Enters Into Warrant Inducement Transaction for up to..
11/10/202322:40EDGAR2Form 8-K - Current report
11/10/202322:30EDGAR2Form 8-K - Current report
28/9/202322:24EDGAR2Form RW - Registration Withdrawal Request
08/9/202322:30EDGAR2Form 8-K - Current report
07/9/202322:30EDGAR2Form 8-K - Current report
14/8/202314:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:31EDGAR2Form 8-K - Current report
10/8/202322:15GLOBEOpGen Reports Second Quarter 2023 Financial Results and..
07/8/202313:30GLOBEOpGen’s Subsidiary Ares Genetics Releases New Features to..
03/8/202314:00GLOBEOpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration..
03/8/202313:30GLOBEOpGen to Provide Business Update and Financial Results for..
01/8/202315:40EDGAR2Form DEF 14A - Other definitive proxy statements
21/7/202322:55EDGAR2Form PRE 14A - Other preliminary proxy statements
19/7/202313:30GLOBEOpGen’s Subsidiary Curetis Meets Milestones of Extended and..
14/7/202322:30EDGAR2Form S-1 - General form for registration of securities under..
05/7/202322:30EDGAR2Form 8-K - Current report
30/6/202322:30EDGAR2Form 8-K - Current report
26/6/202313:30GLOBEOpGen Subsidiary Ares Genetics Successfully Maintains Key..
22/6/202313:30GLOBEOpGen’s Subsidiary Curetis Receives Batch of Ten New..
20/6/202313:30GLOBEOpGen Presents Unyvero Urinary Tract Infection Panel Trial..
15/5/202322:15GLOBEOpGen Reports First Quarter 2023 Financial Results and..
08/5/202313:30GLOBEOpGen to Provide Business Update and Financial Results for..
04/5/202322:30GLOBEOpGen Announces Closing of $3.5 Million Public Offering
02/5/202303:00GLOBEOpGen Announces Pricing of $3.5 Million Public Offering

Dernières Valeurs Consultées

NASDAQ
OPGN
OpGen
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés